|
|
|
|
|
|
1 |
|
|
|
Introduction |
|
|
|
pp. 1-34, 1104-1112 |
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
Receptors/Dose-Response |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
Pharmacokinetics 1 |
|
|
|
pp. 35-50 |
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
Pharmacokinetics 2 |
|
|
|
pp. 75-119, 1020-1021 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
Cholinergic Pharmacology
(Case - Anticholinesterase) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
Pharmacokinetics 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
|
Local Anesthetics |
|
|
|
pp. 436-445, 219-244, 1011-1024 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
|
Antidysrhythmics
(Case - Poison Control)
Clinical Pharmacology in Massachusetts General Hospital Operating Rooms |
|
|
|
pp. 419-435, 446-457 |
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
Drug Metabolism |
|
|
|
pp. 51-63, 564-572, 1072-1073 |
|
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
|
Pharmacogenetics
(Case - Anticoagulation)
(Case - Sulfasalazine) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
|
Autonomic Pharmacology 1 |
|
|
|
pp. 120-154, 333-349 |
|
|
|
|
|
|
|
|
|
|
|
|
12 |
|
|
|
Autonomic Pharmacology 2
(Case - Pheochromocytoma)
(Case - Asthma) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
|
|
Vasoactive Drugs 1 |
|
|
|
pp. 115-218, 245-264, 537-539, 644-659 |
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
Vasoactive Drugs 2
(Case - Cocaine)
(Case - Thyroid Disease) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
|
|
|
Nitric Oxide |
|
|
|
pp. 326-332 |
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
Antiinflammatory Drugs |
|
|
|
pp. 311-318, 596-624, 265-277, 1064-1067 |
|
|
|
|
|
|
|
|
|
|
|
|
17 |
|
|
|
Antihistamines
(Case - Glaucoma)
(Case - Gout) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
Immunopharmacology
(Case - Renal Failure) |
|
|
|
pp. 64-74, 959-986 |
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
Drug Development |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 |
|
|
|
Drugs for Movement Dis. |
|
|
|
pp. 351-363, 463-497, 581-595 |
|
|
|
|
|
|
|
|
|
|
|
|
21 |
|
|
|
Lipid Lowering Drugs
(Case - Placebo)
(Case - Lithium) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 |
|
|
|
Antiolytics/Antidepressants |
|
|
|
pp. 395-418, 498-511, 1025-1035, 382-394 |
|
|
|
|
|
|
|
|
|
|
|
|
23 |
|
|
|
Anticonvulsants
(Case - Placental Transfer)
(Case - Alcohol) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
|
|
|
Antimicrobials 1 |
|
|
|
pp. 754-802, 854-868, 277-288, 981-983 |
|
|
|
|
|
|
|
|
|
|
|
|
25 |
|
|
|
Antimicrobials 2
(Case - Drug Allergy)
(Case - Migraines) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26 |
|
|
|
Chemotherapy 1 |
|
|
|
pp. 923-958, 552-557, 711-734 |
|
|
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
Chemotherapy 2
(Case - Folate)
(Case - Oral Hypoglycemics) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 |
|
|
|
Opioids 1 |
|
|
|
pp. 512-548 |
|
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
Opioids 2
(Case - Cancer, Analgesia)
(Case - Drug Abuse) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
|
|
Final Exam |
|
|
|
|
|
|
|
|
|
|